Progress toward measles preelimination--African Region, 2011-2012.
In 2008, the 46 member states of the World Health Organization (WHO) African Region (AFR) adopted a measles preelimination goal to reach by the end of 2012 with the following targets: 1) >98% reduction in estimated regional measles mortality compared with 2000, 2) annual measles incidence of fewer than five reported cases per million population nationally, 3) >90% national first dose of measles-containing vaccine (MCV1) coverage and >80% MCV1 coverage in all districts, and 4) >95% MCV coverage in all districts by supplementary immunization activities (SIAs). Surveillance performance objectives were to report two or more cases of nonmeasles febrile rash illness per 100,000 population, one or more suspected measles cases investigated with blood specimens in ≥80% of districts, and 100% completeness of surveillance reporting from all districts. This report updates previous reports and describes progress toward the measles preelimination goal during 2011-2012. In 2012, 13 (28%) member states had >90% MCV1 coverage, and three (7%) reported >90% MCV1 coverage nationally and >80% coverage in all districts. During 2011-2012, four (15%) of 27 SIAs with available information met the target of >95% coverage in all districts. In 2012, 16 of 43 (37%) member states met the incidence target of fewer than five cases per million, and 19 of 43 (44%) met both surveillance performance targets. In 2011, the WHO Regional Committee for AFR established a goal to achieve measles elimination by 2020. To achieve this goal, intensified efforts to identify and close population immunity gaps and improve surveillance quality are needed, as well as committed leadership and ownership of the measles elimination activities and mobilization of adequate resources to complement funding from global partners.
Balcha G
BG
Masresha
Reinhard
R
Kaiser
Messeret
M
Eshetu
Reggis
R
Katsande
Richard
R
Luce
Amadou
A
Fall
Annick R G A
AR
Dosseh
Boubker
B
Naouri
Charles R
CR
Byabamazima
Robert
R
Perry
Alya J
AJ
Dabbagh
Peter
P
Strebel
Katrina
K
Kretsinger
James L
JL
Goodson
Deo
D
Nshimirimana
D000349:Africa / Q000453:epidemiology; D060740:Disease Eradication; D005838:Genotype; D006801:Humans; D017589:Immunization Programs; D015994:Incidence; D008457:Measles / Q000453:epidemiology* / Q000517:prevention & control*; D008458:Measles Vaccine / Q000008:administration & dosage; D008459:Measles virus / Q000235:genetics; D011159:Population Surveillance; D014611:Vaccination / Q000706:statistics & numerical data
D008458:Measles Vaccine